ClinicalTrials.Veeva

Menu

Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia

M

Mansoura University

Status

Completed

Conditions

Cesarean Section
Cardiac Output
Anesthesia, Spinal
Echocardiography

Treatments

Drug: Oxytocin
Procedure: Cesarean Delivery
Drug: Crystalloid Coload 1000 mL
Radiation: Transthoracic Echocardiography
Drug: Intrathecal Fentanyl
Drug: Intravenous Ephedrine
Drug: Intrathecal Bupivacaine
Procedure: Spinal Anesthesia

Study type

Observational

Funder types

Other

Identifiers

NCT05269537
MS.20.08.1232

Details and patient eligibility

About

Cardiac output will be measured in healthy parturients undergoing cesarean delivery under spinal anesthesia

Full description

ASA-II women undergoing cesarean delivery under spinal anesthesia will be included. Cardiac output will be measured using transthoracic echocardiography at 4 time points: Baseline, after 10 minutes of intrathecal injection, after delivery, and after 1 hour of intrathecal injection. Spinal anesthesia will be administered with 2.5 ml bupivacaine 0.5% and fentanyl 15 μg.

Enrollment

60 patients

Sex

Female

Ages

19 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists physical status II parturients.
  • Full term, singleton pregnancy
  • Elective cesarean delivery under spinal anesthesia

Exclusion criteria

  • Height <150 cm
  • Weight <60 kg
  • Body mass index (BMI) <18.5 or ≥ 35 kg/m²
  • Women presenting in labor
  • Contraindications to spinal anesthesia: increased intracranial pressure, coagulopathy, or local skin infection
  • Hemoglobin <10 g/dL
  • Current administration of vasoactive drugs (e.g., salbutamol, thyroxin)
  • Diabetes mellitus, cardiovascular, or renal disease
  • Chronic or pregnancy-induced hypertension
  • Polyhydramnios
  • Women with high risk for postpartum hemorrhage or uterine atony (e.g., placenta accreta spectrum, ≥3 previous cesarean deliveries)

Trial design

60 participants in 1 patient group

Study Group
Description:
Cardiac output will be measured at baseline using transthoracic echocardiography. Spinal anesthesia will be administered with injection of intrathecal bupivacaine and intrathecal fentanyl. Crystalloid coload 1000 mL will be administered: Ringer acetate 1000 mL will be administered over 10 minutes starting immediately after intrathecal injection. Cardiac output will be measured at 10 minutes after intrathecal injection, immediately after delivery, at 1 hour after intrathecal injection. Cesarean delivery will be performed. Intravenous ephedrine will be administered to correct hypotension. After delivery, 10 units of oxytocin in 500 ml Ringer acetate will be administered over 30 minutes.
Treatment:
Drug: Intravenous Ephedrine
Procedure: Cesarean Delivery
Procedure: Spinal Anesthesia
Drug: Oxytocin
Drug: Crystalloid Coload 1000 mL
Drug: Intrathecal Bupivacaine
Radiation: Transthoracic Echocardiography
Drug: Intrathecal Fentanyl

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems